PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Update and Appendix 4C - quarterly, page-15

  1. 1,577 Posts.
    lightbulb Created with Sketch. 165
    That’s okay. If it’s not a rude question, who or
    what alerted you to the fact that Prolia was the
    cause of the failure of the iPPS injections?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.